- Open Systems
- Closed Systems
Pharmaceutical Isolator Market size was valued at USD 10,204.3 million in 2022 and expected to reach USD 13,424.3 million in 2029, at a CAGR of 5.3% during the forecast period 2023 to 2029. A few efficient Advancements like connectivity, portability, and grabbing the stationary position make isolators to be used around several applications. Such features of pharmaceutical isolators influence the pharmaceutical market. Increasing the use of aseptic methods is another market-fueling factor. Lancing and addition of novel products making use of pharmaceutical isolators is another crucial factor leading towards the growth of the market. For example, the first injectable clinical batch is manufactured by Amatsigroup in 2017 under a single-use isolator. Constant isolation is provided to the interior from the external environment through a pharmaceutical isolator. Pharmaceutical isolators are mainly used to handle quality control processes, drugs, and materials to be isolated totally from the environment. These isolators are available in different shapes and sizes. Several industries demand these isolators according to their applicability. This market research report provides insights into market dynamics. It also covers drivers, trends, restraints, and opportunities. This report also represents a huge outlook of the industry players. It also gives thorough information about investment and profit analysis and research and development of the industry players dominating the pharmaceutical isolator market.
Pharmaceutical Isolator Market Key Developments:
- In April 2021, ILC Dover launched flexible aseptic isolator soloPURE for pharma and biopharma processing.
- In November 2017, Ansell Limited acquired gammaSUPPLIES, a company that specializes in Validated Sterile RABS/Isolator long glovesused in pharmaceutical and biologic manufacturing facilities around the globe
Global Pharmaceutical Isolator Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
5.3%
Largest Market
Asia-Pacific
Fastest Growing Market
North-America
Pharmaceutical Isolator Market Dynamics
There is increasing demand for pharmaceutical isolators from pharmaceutical and biotechnological sectors, which in turn boom the market growth. Another market boosting factor is increasing demand from both small scale and midscale industries. Increasing execution of rules to make sure the safety of the pharmaceuticals techniques is also enhancing the use of pharmaceuticals isolators. A few other factors stimulating the global pharmaceutical isolators market are cost of noncompliance, increasing use of sterilized methods, developments in isolator efficiency and increasing research laboratories. In addition, pharmaceutical isolators have the potent to handle the risky materials efficiently along with launching of new products is leading towards the market growth hugely.
North-America Got Significant Share
Pharmaceutical Isolator Market Regional Analysis
The pharmaceutical isolator market is segmented into North America, Asia Pacific, Middle East and Africa, Europe and Latin America. Among all the regions, North America is anticipated to hold the huge market share because of rapid acceptance of advanced healthcare products. On the other hand, Asia Pacific is anticipated to expand with a profitable CAGR because of increasing investment done by key players in the pharmaceutical isolators to fulfill the unmet requirements of the pharmaceutical segment.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The pharmaceutical isolator market report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and Forecast (2023 to 2029)
- The report covers in-detail insights about the competitors overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startups details that are actively working in the market
- The report provides a plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porters Five Force Analysis in addition to recent technology advancements and innovations in the market
Global Pharmaceutical Isolator Market Segmentation
By System
By Type
- Bio Isolators
- Aseptic Isolators
- Sampling, Weighing, And Distribution Isolators
- Containment Isolators
- Active Pharmaceutical Ingredient & Manufacturing Isolators
- Others
By End-user
- Pharmaceutical And Biotechnological Industries
- Hospitals And Diagnostics Labs
- Research And Academics
- Others
Frequently Asked Questions
The pharmaceutical isolator market is projected to expand at a CAGR of 5.3% during the forecast period
Azbil Telstar, Skan AGGetinge AB, NuAire Inc, MBRAUN, IsoTech Design
North America is the fastest-growing region for the pharmaceutical isolator market
| 1.Executive Summary |
| 2.Global Pharmaceutical Isolator Market Introduction |
| 2.1.Global Pharmaceutical Isolator Market - Taxonomy |
| 2.2.Global Pharmaceutical Isolator Market - Definitions |
| 2.2.1.System |
| 2.2.2.Type |
| 2.2.3.End User |
| 2.2.4.Region |
| 3.Global Pharmaceutical Isolator Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Pharmaceutical Isolator Market Analysis, 2018-2022 and Forecast 2023-2029 |
| 4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Pharmaceutical Isolator Market By System, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 5.1. Open Systems |
| 5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Closed Systems |
| 5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 6.Global Pharmaceutical Isolator Market By Type, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 6.1. Bio Isolators |
| 6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Aseptic Isolators |
| 6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Sampling, Weighing, And Distribution Isolators |
| 6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Containment Isolators |
| 6.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Active Pharmaceutical Ingredient & Manufacturing Isolators |
| 6.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 6.6. Others |
| 6.6.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.6.3. Market Opportunity Analysis |
| 7.Global Pharmaceutical Isolator Market By End User, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 7.1. Pharmaceutical And Biotechnological Industries |
| 7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Hospitals And Diagnostics Labs |
| 7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Research And Academics |
| 7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Others |
| 7.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 8.Global Pharmaceutical Isolator Market By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9.North America Pharmaceutical Isolator Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 9.1. System Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Open Systems |
| 9.1.2.Closed Systems |
| 9.2. Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Bio Isolators |
| 9.2.2.Aseptic Isolators |
| 9.2.3.Sampling, Weighing, And Distribution Isolators |
| 9.2.4.Containment Isolators |
| 9.2.5.Active Pharmaceutical Ingredient & Manufacturing Isolators |
| 9.2.6.Others |
| 9.3. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Pharmaceutical And Biotechnological Industries |
| 9.3.2.Hospitals And Diagnostics Labs |
| 9.3.3.Research And Academics |
| 9.3.4.Others |
| 9.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10.Europe Pharmaceutical Isolator Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 10.1. System Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Open Systems |
| 10.1.2.Closed Systems |
| 10.2. Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Bio Isolators |
| 10.2.2.Aseptic Isolators |
| 10.2.3.Sampling, Weighing, And Distribution Isolators |
| 10.2.4.Containment Isolators |
| 10.2.5.Active Pharmaceutical Ingredient & Manufacturing Isolators |
| 10.2.6.Others |
| 10.3. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Pharmaceutical And Biotechnological Industries |
| 10.3.2.Hospitals And Diagnostics Labs |
| 10.3.3.Research And Academics |
| 10.3.4.Others |
| 10.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 10.4.6.Rest of EU |
| 11.Asia Pacific (APAC) Pharmaceutical Isolator Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 11.1. System Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Open Systems |
| 11.1.2.Closed Systems |
| 11.2. Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Bio Isolators |
| 11.2.2.Aseptic Isolators |
| 11.2.3.Sampling, Weighing, And Distribution Isolators |
| 11.2.4.Containment Isolators |
| 11.2.5.Active Pharmaceutical Ingredient & Manufacturing Isolators |
| 11.2.6.Others |
| 11.3. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Pharmaceutical And Biotechnological Industries |
| 11.3.2.Hospitals And Diagnostics Labs |
| 11.3.3.Research And Academics |
| 11.3.4.Others |
| 11.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12.Middle East and Africa (MEA) Pharmaceutical Isolator Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 12.1. System Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Open Systems |
| 12.1.2.Closed Systems |
| 12.2. Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Bio Isolators |
| 12.2.2.Aseptic Isolators |
| 12.2.3.Sampling, Weighing, And Distribution Isolators |
| 12.2.4.Containment Isolators |
| 12.2.5.Active Pharmaceutical Ingredient & Manufacturing Isolators |
| 12.2.6.Others |
| 12.3. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Pharmaceutical And Biotechnological Industries |
| 12.3.2.Hospitals And Diagnostics Labs |
| 12.3.3.Research And Academics |
| 12.3.4.Others |
| 12.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13.Latin America Pharmaceutical Isolator Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 13.1. System Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Open Systems |
| 13.1.2.Closed Systems |
| 13.2. Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Bio Isolators |
| 13.2.2.Aseptic Isolators |
| 13.2.3.Sampling, Weighing, And Distribution Isolators |
| 13.2.4.Containment Isolators |
| 13.2.5.Active Pharmaceutical Ingredient & Manufacturing Isolators |
| 13.2.6.Others |
| 13.3. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Pharmaceutical And Biotechnological Industries |
| 13.3.2.Hospitals And Diagnostics Labs |
| 13.3.3.Research And Academics |
| 13.3.4.Others |
| 13.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Fedegari Autoclavi SpA |
| 14.2.2.Azbil Telstar |
| 14.2.3.Robert Bosch GmbH, Hosokawa Micron Ltd |
| 14.2.4.Skan AGGetinge AB |
| 14.2.5.NuAire Inc. |
| 14.2.6.MBRAUN |
| 14.2.7.IsoTech Design |
| 14.2.8.Schematic Engineering Industries |
| 14.2.9.Gelman Singapore Pte Ltd |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
- Fedegari Autoclavi SpA
- Azbil Telstar
- Robert Bosch GmbH, Hosokawa Micron Ltd
- Skan AGGetinge AB
- NuAire Inc.
- MBRAUN
- IsoTech Design
- Schematic Engineering Industries
- Gelman Singapore Pte Ltd